Author Archives: admin

Ricky Reyes to help set up Fresh Cell Therapy clinic in the Philippines

By adminOctober 13, 2012Uncategorized

Hanggang ngayon ay usap-usapan pa rin ang Fresh Cell Therapy (FCT) o mas kilala natin bilang stem cell therapy lalo nat marami nang celebrities ang nahihikayat na sumailalim sa naturang medical procedure na nagpo-promote ng anti-aging at nakatutulong para labanan ang ilang serious health conditions.

Isa na nga rito ang sikat na hairstylist, beauty expert, philanthropist, businessman, at TV host na si Ricky Reyes o mas kilala bilang si Mother Ricky.

Sumailalim si Mother Ricky sa FCT noong Hunyo ng taong ito at ngayon nga ay ine-enjoy niya ang benepisyo nito sa kanyang kalusugan.

The fact that my arthritis is gone, Im very, very happy and Im thankful to Bobby [Kittichaiwong, Villa Medica CEO). And its just a two-shot on my back, gone instantly. You know, yung quality of life mo na hindi ka aray-aray-aray?

Tapos nagpunta ako sa Germany last June and its such a beautiful place. We even had meron ka pang tour sa Paris [France]. Very nice place, sabi ni Mother Ricky.

Nakausap ng PEP.ph (Philippine Entertainment Portal) si Mother Ricky sa presscon ng Villa Medica tungkol sa FCT na ginanap kaninang tanghali, Oktubre 13, sa Crowne Plaza sa Ortigas, Pasig City.

Hindi rin daw niya maitatanggi ang kabutihang naidulot ng FCT sa kanyang ina, na sumailalim din sa naturang therapy.

Oo naman, with my experience with my mom. Dati nakatungo na, ngayon nakataas na yung leeg na ganyan, paglalarawan pa ni Mother Ricky tungkol sa nagawa ng FCT sa kanyang ina.

Nai-stretch na yung mga kamay. Isang malaking utang na loob ko yun kay Bobby. It is a Christmas gift of Bobby to me to cure my mom.

U.S. hospital: No record of researcher's iPS trial

By adminOctober 13, 2012Stem Cell Treatment

Sunday, Oct. 14, 2012

BOSTON The U.S. hospital where researcher Hisashi Moriguchi claimed to have conducted a cutting-edge stem-cell treatment said Friday there are no records of him having undertaken the procedure or applying for approval to carry it out.

Moriguchi earlier said he had conducted the procedure on six patients at Massachusetts General Hospital, affiliated with Harvard University, where induced pluripotent stem (iPS) cells produced from the livers of the patients, who were suffering from heart disease, were transplanted after growing them into heart muscle cells.

When confronted by reporters Friday in New York, however, Moriguchi was evasive about whether he actually performed the clinical procedure. "I would like to tell you the truth" on another occasion, he said.

Citing a hearing from a doctor who has coauthored reports with Moriguchi, the Massachusetts hospital said that "Dr. (Raymond) Chung has no knowledge of the clinical procedure that Dr. Moriguchi reported" recently at a stem-cell confab in New York.

"We cannot find any evidence of that procedure taking place at Massachusetts General Hospital," the hospital said in a statement. "No request to conduct that sort of clinical trial was ever submitted or approved" by the hospital's institutional review board, which reviews and approves all studies involving human patients.

"There is no evidence in the records of the Harvard University Institutional Review Board or the Institutional Review Board of Harvard Medical School of Moriguchi applying for permission to carry out any experiment of any kind," the hospital added.

A public relations official at the hospital said it believes a 34-year-old man with heart disease that Moriguchi claimed was the first of the six patients to receive a transplant does not exist.

The official said the hospital could not find any records indicating that the procedure claimed to have been taken by Moriguchi was applied to a patient at the hospital during the time when the man allegedly received the transplant.

Moriguchi identified himself as a visiting lecturer at Harvard, but the university has since said he currently has no affiliation with either it or the Massachusetts hospital.

View original post here:
U.S. hospital: No record of researcher's iPS trial

Neural-Like Stem Cells From Muscle Tissue May Hold Key to Cell Therapies for Neurodegenerative Diseases

By adminOctober 13, 2012Stem Cell Medical Center

Newswise WINSTON-SALEM, N.C. Oct. 12, 2012 Scientists at Wake Forest Baptist Medical Center have taken the first steps to create neural-like stem cells from muscle tissue in animals. Details of the work are published in two complementary studies published in the September online issues of the journals Experimental Cell Research and Stem Cell Research.

Reversing brain degeneration and trauma lesions will depend on cell therapy, but we cant harvest neural stem cells from the brain or spinal cord without harming the donor, said Osvaldo Delbono, M.D., Ph.D., professor of internal medicine at Wake Forest Baptist and lead author of the studies.

Skeletal muscle tissue, which makes up 50 percent of the body, is easily accessible and biopsies of muscle are relatively harmless to the donor, so we think it may be an alternative source of neural-like cells that potentially could be used to treat brain or spinal cord injury, neurodegenerative disorders, brain tumors and other diseases, although more studies are needed.

In an earlier study, the Wake Forest Baptist team isolated neural precursor cells derived from skeletal muscle of adult transgenic mice (PLOS One, Feb.3, 2011).

In the current research, the team isolated neural precursor cells from in vitro adult skeletal muscle of various species including non-human primates and aging mice, and showed that these cells not only survived in the brain, but also migrated to the area of the brain where neural stem cells originate.

Another issue the researchers investigated was whether these neural-like cells would form tumors, a characteristic of many types of stem cells. To test this, the team injected the cells below the skin and in the brains of mice, and after one month, no tumors were found.

Right now, patients with glioblastomas or other brain tumors have very poor outcomes and relatively few treatment options, said Alexander Birbrair, a doctoral student in Delbonos lab and first author of these studies. Because our cells survived and migrated in the brain, we may be able to use them as drug-delivery vehicles in the future, not only for brain tumors but also for other central nervous system diseases.

In addition, the Wake Forest Baptist team is now conducting research to determine if these neural-like cells also have the capability to become functioning neurons in the central nervous system.

Co-authors of the studies are Tan Zhang, Ph.D., Zhong-Min Wang, M.S., Maria Laura Messi, M.S., Akiva Mintz, M.D., Ph.D., of Wake Forest Baptist, and Grigori N. Enikolopov, Ph.D., of Cold Spring Harbor Laboratory.

The present studies were supported by a PUSH grant from the Wake Forest Baptist Comprehensive Cancer Center to Drs. Akiva Mintz and Osvaldo Delbono; National Institute on Aging contract AG13934 and AG15820; the Claude D. Pepper Older Americans Independence Center of Wake Forest Baptist Medical Center grant P30-AG21332, and the National Institute of Aging grant R01AG040209.

Stem cells from muscle tissue may hold key to cell therapies for neurodegenerative diseases

By adminOctober 13, 2012Stem Cell Medical Center

Scientists at Wake Forest Baptist Medical Center have taken the first steps to create neural-like stem cells from muscle tissue in animals. Details of the work are published in two complementary studies published in the September online issues of the journals Experimental Cell Research and Stem Cell Research.

"Reversing brain degeneration and trauma lesions will depend on cell therapy, but we can't harvest neural stem cells from the brain or spinal cord without harming the donor," said Osvaldo Delbono, M.D., Ph.D., professor of internal medicine at Wake Forest Baptist and lead author of the studies.

"Skeletal muscle tissue, which makes up 50 percent of the body, is easily accessible and biopsies of muscle are relatively harmless to the donor, so we think it may be an alternative source of neural-like cells that potentially could be used to treat brain or spinal cord injury, neurodegenerative disorders, brain tumors and other diseases, although more studies are needed."

In an earlier study, the Wake Forest Baptist team isolated neural precursor cells derived from skeletal muscle of adult transgenic mice (PLOS One, Feb.3, 2011).

"Right now, patients with glioblastomas or other brain tumors have very poor outcomes and relatively few treatment options," said Alexander Birbrair, a doctoral student in Delbono's lab and first author of these studies. "Because our cells survived and migrated in the brain, we may be able to use them as drug-delivery vehicles in the future, not only for brain tumors but also for other central nervous system diseases."

In addition, the Wake Forest Baptist team is now conducting research to determine if these neural-like cells also have the capability to become functioning neurons in the central nervous system.

Journal reference: PLoS ONE

Provided by Wake Forest University Baptist Medical Center

Originally posted here:
Stem cells from muscle tissue may hold key to cell therapies for neurodegenerative diseases

Laboratory Sperm Creation Available Within Two Years: British Online Clinic Uk-Med.co.uk Releases a report that looks …

By adminOctober 13, 2012Stem Cell Clinic

Last year, Kyoto University in Japan, managed to create eggs and sperm in mice that were successfully fertilized through to baby mice being born. Now an American research team are stepping up their attempts to produce human sperm using stem cells.

London, UK (PRWEB UK) 12 October 2012

The inability to conceive a baby can have many reasons which affect either the female or male or both, that are involved in creating an offspring. Where actual fertility is concerned there are stages throughout a woman and a mans life when their ability to conceive easily occurs. The younger you are when you attempt to have children, the better. With a lot of couples establishing their careers and leaving it till later to start a family, there is bound to be more couples that will require investigating, which leads to fertility treatment.

Worry involved with infertility can cause other side effects, such as erectile dysfunction and stress can be a key factor in ED. Viagra or Cialis are good treatments for this possibly temporary problem.

This research is highly controversial as it uses embryonic stem cells because they provide the best start. Stem cells are part of multicellular organisms that via mitosis can form any cell type. This makes them so versatile when used to grow cells for bone marrow, body organs, repairing nerves or actually any cell in the human body.

There has always been objections to this medical research as cells are harvested from embryos. Dr Reijo Pera obtains the stem cells from the extra eggs that are not needed after IVF treatments. IVF clinics in America make 1 to 1.5 million ova a year and of these, 500,000 are disposed of. Seemingly many are concerned over the 500 being used to enhanced medical procedures and the health of the overall population, instead of the yearly disposal of 500,000 eggs that could be used in lifesaving treatment.

With the ground breaking achievements made by Japanese scientists in making baby mice from sperm and eggs that were grow with stem cells, it has given the US team a boost for their studies to go to the next stage and create a human baby in this way. Being able to produce a viable fertilised egg to be implanted by this method would help so many childless couples. Also the implications as to extending the length of childbearing years of women could be of benefit for those postponing parenthood.

All this said there are factors of opposition to stem cells being used and should women be able to have a baby in later years. So who is going to be brave enough to allow general use of stem cells recovered from embryos and decide how old is too old for a woman to give birth.

Written by Frances Cerulean

Article Source : http://www.uk-med.co.uk/Health/Laboratory-Sperm-Creation-Available-Within-Two-Years

More here:
Laboratory Sperm Creation Available Within Two Years: British Online Clinic Uk-Med.co.uk Releases a report that looks ...

Leading Researchers to Unite at Texas State Capitol for Regenerative Medicine and Stem Cell Research

By adminOctober 13, 2012Uncategorized

AUSTIN, Texas, Oct. 12th, 2012 /PRNewswire-USNewswire/ -- Prominent stem cell scientists, physicians, and advocates from leading medical facilities and research institutions across Texas and California will highlight the 3rd Annual Stem Cell Research Symposium: Spotlight on Texas, on October 19, 2012, at the Texas State Capitol.

This free, public symposium, produced and co-hosted by the Austin-based nonprofit Texas Cures Education Foundation (Texas Cures), is designed to educate the public about the exciting stem cell research andclinical trials currently under way in Texas.The event will also include a discussion of recent Texas laws affecting stem cell research, the potential economic impact of stem cell research and highlight the current progress in one of the most promising areas of medicine.

This year, more than a dozen local and national advocacy groups, institutions and foundations showed their support for the efforts of the hosting organizations Texas Cures and Texans for Stem Cell Research including the Genetics Policy Institute, Alliance for Regenerative Medicine and Texans for Advancement of Medical Research.

The symposium begins at 8:30 a.m. in the Capitol Extension Auditorium (E1.004), located at the Texas State Capitol Building. Admission is free and open to the public.Registration is recommended.

This program unites the diverse stem cell research and regenerative medicine community to provide a unified voice for promising science that holds unmatched potential to benefit patients. Leading speakers at the event will include:

For additional details about the program and presentation topics, please visit TexasCures.org.

The 3rd Annual Stem Cell Research Symposium: Spotlight on Texas is an official World Stem Cell Awareness Day Event. Follow @TexasCures and #stemcellday for live Twitter updates and announcements.

Texas Cures Education Foundation (Texas Cures) TexasCures.orgis a non-partisan, nonprofit 501(c)3] organization based in Austin, Texas. It was founded for the purpose of advancing knowledge of the life-saving work that doctors and researchers perform every day on behalf of patients and their families. Texas Cures facilitates stem cell public education for the betterment of healthcare and the growth of companies, research hospitals, and institutions, charities, and volunteer patient group organizations that include a broad range of regenerative medicine stakeholders. Texas Cures advocates for responsible public policy and encourages legislative and regulatory proposals that expand access to stem cell clinical applications.

SOURCE Texas Cures Education Foundation

Follow this link:
Leading Researchers to Unite at Texas State Capitol for Regenerative Medicine and Stem Cell Research

Stem-cell transplant claims debunked

By adminOctober 13, 2012Stem Cell Treatment

Hisashi Moriguchi presented his work at the New York Stem Cell Foundation meeting this week.

AP/Press Association

From the beginning, it seemed too good to be true. Days after Kyoto University biologist Shinya Yamanaka won a Nobel prize for his 2006 discovery of induced pluripotent stem (iPS) cells (see 'Cell rewind wins medicine Nobel'), Hisashi Moriguchi a visiting researcher at the University of Tokyo claimed to have modified that technology to treat a person with terminal heart failure. Eight months after surgical treatment in February, said a front-page splash in the Japanese newspaper Yomiuri Shimbun yesterday, the patient was healthy.

But after being alerted to the story by Nature, Harvard Medical School and Massachusetts General Hospital (MGH), where Moriguchi claimed to have done the work, denied that the procedure had taken place. No clinical trials related to Dr Moriguchi's work have been approved by institutional review boards at either Harvard University or MGH, wrote David Cameron, a spokesman for Harvard Medical School in Boston, Massachusetts. The work he is reporting was not done at MGH, says Ryan Donovan, a public-affairs official at MGH, also in Boston.

A video clip posted online by the Nippon News Network and subsequently removed showed Moriguchi presenting his research at the New York Stem Cell Foundation meeting this week.

If true, Moriguchis feat would have catapulted iPS cells into use in a wide range of clinical situations, years ahead of most specialists' predictions. I hope this therapy is realized in Japan as soon as possible, the head of a Tokyo-based organization devoted to helping children with heart problems told Yomiuri Shimbun.

But there were reasons to be suspicious. Moriguchi said he had invented a method to reprogram cells using just two chemicals: microRNA-145 inhibitor and TGF- ligand1. But Hiromitsu Nakauchi, a stem-cell researcher at the University of Tokyo, says that he has never heard of success with that method. He adds that he had also never heard of Moriguchi before this week.

Moriguchi also said that the cells could be differentiated into cardiac cells using a 'supercooling' method that he had invented. Thats another weird thing, says Nakauchi.

The article in which Moriguchi presented his two-chemical method, published in a book1 describing advances in stem-cell research, includes paragraphs copied almost verbatim from other papers. The section headed 2.3 Western blotting, for example, is identical to a passage from a 2007 paper by Yamanaka2. Section 2.1.1, in which Moriguchi describes human liver biopsies, matches the number of patients and timing of specimen extractions described in an earlier article3, although the name of the institution has been changed.

When contacted by Nature, Moriguchi stood by his publication. We are all doing similar things so it makes sense that wed use similar words, he says. He did admit to using other papers as reference.

Link:
Stem-cell transplant claims debunked

Bay Area stem cell researchers see encouraging results

By adminOctober 13, 2012Stem Cell Treatment

SAN FRANCISCO (KGO) -- Bay Area stem cell researchers are reporting early, encouraging results from two clinical trials. The first, involves patients, paralyzed with spinal cord injuries and a treatment that could offer new hope for their future.

Nearly 20 years after the football injury that left him paralyzed, Roman Reed still holds onto the hope that he will someday walk again.

"One hundred percent, without a doubt. I've been wrong about the date, but not the fact I will walk again," said Reed.

Reed now runs a foundation to promote stem cell research and has been closely watching a clinical trial being conducted by Bay Area based Stem Cells Inc. Its goal is to use stem cell therapy to restore motor function in patients with spinal cord injuries.

"We're on the road on to being able to cure paralysis, it's so important, and stem cells are the way to do it," said Reed.

Stephen Huhn, M.D., Ph.D., from Stem Cells Inc., says the test procedure began a two hour surgery to clear a path to the spinal cord. Researchers then injected the cells directly into the damaged area.

"So the first three patients in the trial were designed to enroll patients who had the worst of the worst injuries. In other words, complete loss of sensory function and complete loss of motor function below the level of injury," said Huhn.

The phase one trials are all about establishing safety, but six months out, the researchers began measuring some intriguing improvements in two of those three patients. Both reported feeling in areas below the areas of their injuries.

The company cautions that the data is very preliminary, but they say researchers were able to measure the improved sensory response using several testing methods, including electrical stimulation, and response to heat -- which are considered more accurate than the patient's own self-reporting.

"You can't fake that. When we saw that data, that's when we became very excited," said Martin McGlynn, the CEO of Stems Cells Inc.

Follow this link:
Bay Area stem cell researchers see encouraging results

Doubt cast on clinical stem cell tests

By adminOctober 12, 2012Stem Cell Treatment

Friday, Oct. 12, 2012

Harvard University said neither it nor Massachusetts General Hospital have ever authorized any iPS-related clinical studies by Hisashi Moriguchi, who claims to have achieved the first clinical application using the revolutionary stem cell technology.

"No clinical trials related to Moriguchi's work have been approved by institutional review boards at either Harvard University or Massachusetts General Hospital," a statement issued by Harvard and related institutes said Thursday.

The statement confirmed that Moriguchi "was a visiting fellow at Massachusetts General Hospital from 1999-2000," but added that he "has not been associated with (the institution) or Harvard since that time."

Moriguchi, a researcher at University of Tokyo Hospital, claimed to be a visiting lecturer at Harvard and to have conducted clinical trials at Massachusetts General Hospital with other researchers to transplant artificial cardiac muscle cells developed from iPS cells into six patients with heart disease.

The claim came just after Shinya Yamanaka of Kyoto University and a British scholar were jointly awarded this year's Nobel Prize in physiology or medicine for their research on iPS cells. Yamanaka and John Gurdon were credited with the discovery that mature human cells can be reprogrammed as immature cells capable of developing into all types of body parts.

"Research has been conducted after going through due procedures, such as consultations with a university ethics committee," Moriguchi claimed. "I have been told my method of creating iPS cells is different from the one used by Yamanaka (and Gurdon), but I have been doing it my way and no problems have been identified after transplants."

Moriguchi, who is thought to have asked a heart surgeon to carry out cell transplants, unveiled details about the treatment at a meeting of annual stem-cell research conference at Rockefeller University in New York held Wednesday and Thursday.

But the event's organizer, the nonprofit New York Stem Cell Foundation, subsequently said it "has received information from Harvard University that raises legitimate questions concerning a poster presentation" by Moriguchi, and has withdrawn it from the conference.

Moriguchi graduated from Tokyo Medical and Dental University with a degree in nursing science and does not have a license to practice medicine, according to a professor who taught him as an undergraduate.

See the original post:
Doubt cast on clinical stem cell tests

Regenevéda Opens Flagship Stem Cell Therapy Clinic in Beverly Hills

By adminOctober 12, 2012Stem Cell Treatment

Beverly Hills, CA (PRWEB) October 12, 2012

Regenevda (http://www.regeneveda.com) recently opened its brand new flagship facility in Beverly Hills. Founded by world renowned surgeon Dr. Thom Lobe, Regenevda specializes in cutting edge anti-aging treatments such as Stem Cell Therapy, IV Vitamin Therapy, and HGH Therapy.

Dr. Thom Lobe is an internationally respected surgeon and has been in practice for over 30 years. Consistently pioneering advances in medicine, Dr. Lobe was one of the first doctors to ever separate conjoined twins. Consistently working to help make advances in medicine, Dr. Lobe also has over 200 publications to his credit.

Overseeing the business aspect of Regenevda is Lindsey Combs. She is responsible for sales, staff, accounting, facility management, and business development. A graduate of the University of California, Los Angeles, Ms. Combs has been working in the anti-aging field for over 10 years and has been a California Licensed Esthetician since 2003.

Being one of the very few physicians in the country to hold the most advanced board certification (FAARM), Dr. Lobe is able to offer Stem Cell Therapy at the Regenevda clinic. Inside each persons own body, there are special cells in nearly every organ and tissue that have the ability to help heal damage. These special cells are called Stem Cells and this therapy works by harvesting these cells from a persons own blood, bone marrow, or fat and can help with different conditions. Some examples of procedures that use Stem Cell Therapy are: Stem Cell Facelifts, Stem Cell Breast Augmentation, and Stem Cell Joint Therapy. Stem Cell treatments are safe, non-invasive, and are done under local anesthesia.

Intravenous Nutrition Therapy (or IV Vitamin Therapy) is another anti-aging and rejuvenation treatment that can also help patients prevent migraines, lose weight, fight chronic infections like hepatitis, candida, lyme disease, as well as fight acute infections like the flu and mono. IV Therapy works by using intravenous solutions to deliver vitamins and minerals directly to the body cells. This bypasses the digestive system and provides a more direct method of delivery, which ensures that all of the nutrients required are delivered, allowing the patient to feel an improvement in condition almost immediately.

Human Growth Hormone (HGH) Therapy is another advanced treatment offered at Regenevda. HGH is secreted by the Pituitary gland and fuels cell growth and reproduction. This production peaks at adolescence. Over time, due to the effect of aging, the production of HGH slows down dramatically. As production declines, it makes it more difficult for the body to recover from physical and mental exertion. HGH Therapy acts as a supplement for HGH deficient adults to lessen body fat, boost lipid lineament, improve memory, promote bone density, as well as decrease risk factors that involve cardio-vascular conditions. If used at the onset of the decrease in HGH production, HGH Therapy can help curtail early aging and even be used as preventive measure against osteoporosis. A complete analysis of the patients sex hormones, evaluation of glucose regulation and functions of the adrenal gland, thyroid gland, and pancreas are performed before the treatment is administered for optimal results.

Combining decades of medical experience with the most cutting edge advances in medical technology, the Regenevda clinic looks to pave the way for the future of anti-aging treatments. The Regenevda Beverly Hills Institute of Cellular Therapy is located at 50 North La Cienega Boulevard. For any inquiries, they can be reached at 855-734-3638, or visit http://www.regeneveda.com.

About Regenevda :

Regeneveda, home of The Beverly Hills Institute of Cellular Therapy, provides state-of-the-art Stem Cell Therapy. Stem Cell Therapy is an effective treatment for chronic conditions such as Arthritis, Diabetes, Chronic Sports Injuries, and Chronic Pain, but is also revolutionizing anti-aging treatments such as Breast Enhancement, Erectile Dysfunction, and Facial Aging.

See more here:
Regenevéda Opens Flagship Stem Cell Therapy Clinic in Beverly Hills